The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review

There is a vital role of B cells in the pathogenesis of Systemic Lupus Erythematosus (SLE). Belimumab (Bel), an inhibitor of B cell activating factor (BAFF), and Rituximab (RTX), a monoclonal antibody targeting Cd20 antigen, have been used to manage systemic lupus. Several randomized controlled tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Naushad, Manaye, Sara, Naushad, Hamzah, Cheran, Kaaviya, Murthy, Chinmayee, Bornemann, Elisa A, Kamma, Hari Krishna, Alabbas, Mohammad, Elashahab, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360028/
https://www.ncbi.nlm.nih.gov/pubmed/37485087
http://dx.doi.org/10.7759/cureus.40719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360028/
https://www.ncbi.nlm.nih.gov/pubmed/37485087
http://dx.doi.org/10.7759/cureus.40719

Ejemplares similares